Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines

International Journal of Biochemistry and Cell Biology

Volumn 30, Issue 7, 1998, Pages 833-842

  Wilson, Paul K ^a   Szabados, Eve ^a   Mulligan, Stephen P ^b   Christopherson, Richard I ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Geriatric Medicine   (Australia)

Author keywords

Cladribine; Fludarabine; Leukaemia; Nucleotides; Pentostatin

Indexed keywords

2' DEOXYNUCLEOSIDE; CLADRIBINE; FLUDARABINE; NUCLEOSIDE TRIPHOSPHATE; PENTOSTATIN; PERCHLORIC ACID;

ARTICLE; CANCER GRADING; CYTOTOXICITY; HAIRY CELL LEUKEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LYMPHOMA; NUCLEOTIDE METABOLISM; RAJI CELL; REMISSION; ULTRAVIOLET RADIATION;

ADENOSINE DEAMINASE; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CELL DIVISION; CLADRIBINE; DEOXYRIBONUCLEOTIDES; ENZYME INHIBITORS; HUMANS; KINETICS; LEUKEMIA, T-CELL; LYMPHOMA, B-CELL; PENTOSTATIN; RIBONUCLEOTIDES; TUMOR CELLS, CULTURED; VIDARABINE;

ARA; VIOLA (ANGIOSPERM);

EID: 0032127273     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00024-7     Document Type: Article

References (27)

1. Agarwal R.P., Parks R.E. Potent inhibition of muscle 5′-AMP deaminase by the nucleoside antibiotics coformycin and deoxycoformycin. Biochem. Pharmacol. 26:1977;663-666.
2. Agarwal R.P., Spector T., Parks R.E. Jr. Tight-binding inhibitors. IV. Inhibition of adenosine deaminases by various inhibitors. Biochem. Pharmacol. 26:1977;359-367.
3. R.L. Blakley, M.C. Huang, R.A. Ashmun, R. Koob, Mechanism of cytotoxicity of 2-chloro and 2-bromodeoxyadenosine for a human lymphoblastic cell line, CCRF-CEM, in: W.L. Nyhan, L.F. Thompson, R.W.E. Watts (Eds.), Advances in Experimental Medicine and Biology, vol. 195B: Purine and Pyrimidine Metabolism in Man, V, Part B: Basic Science Aspects, Plenum Publishing, New York, 1986, pp. 589-593.
4. Carson D.A., Wasson D.B., Kaye J., Ullman B., Martin D.W. Jr., Robins R.K., Montgomery J.A. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo. Proc. Natl. Acad. Sci. 77:1980;6865-6869.
5. Crisp L.B., Smith S.M., Mathers M.A., Young G.A., Lyons S.D., Christopherson R.I. Effects of cytosine arabinoside on human leukemia cells. Int. J. Biochem. Cell Biol. 28:1996;1061-1069.
6. Dow L.W., Bell D.E., Poulakos L., Fridland A. Differences in metabolism and cytotoxicity between 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts. Cancer Res. 40:1980;1405-1410.
7. Duggleby R.G. Regression analysis of nonlinear Arrhenius plots: an empirical model and a computer program. Comput. Biomed. Res. 14:1984;447-455.
8. Eriksson S., Thelander L., Akerman M. Allosteric regulation of calf thymus ribonucleoside diphosphate reductase. Biochemistry. 18:1979;2948-2952.
9. Garrett C., Santi D.V. A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal Biochem. 99:1979;268-273.
10. Gandhi V., Estey E., Keating M.J., Chucrallah A., Plunkett W. Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic and molecular interactions. Blood. 87:1996;256-264.
11. Hentosh P., Grippo P. Template 2-chloro-2′-deoxyadenosine monophosphate inhibits in vitro DNA synthesis. Mol. Pharmacol. 45:1994;955-961.
12. Huang P., Plunkett W. Action of 9-β-D-arabinosyl-2-fluoroadenine on RNA metabolism. Mol. Pharmacol. 39:1991;449-455.
13. Kay A.C., Saven A., Carrera C.J., Carson D.A., Thurston D., Beutler E., Piro L.D. 2-chlorodeoxyadenosine treatment of low-grade lymphomas. J. Clin. Oncol. 10:1992;371-377.
14. Li L., Liu X., Glassman A.B., Keating M.J., Stros M., Plunkett W., Yang L.Y. Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. Cancer Res. 57:1997;1487-1494.
15. Parker W.B., Bapat A.R., Shen J.- X., Townsend A.J., Cheng Y.- C. Interaction of 2-halogenated dATP analogs (F, Cl and Br) with human DNA polymerases, DNA primase and ribonucleotide reductase. Mol. Pharmacol. 34:1988;485-491.
16. Piro L.D., Carrera C.J., Beutler E., Carson D.A. 2-chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood. 72:1988;1069-1073.
17. Piro L.D., Carrera C.J., Carson D.A., Beutler E. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N. Engl. J. Med. 322:1990;1117-1121.
18. Plunkett W., Chubb S., Alexander L., Montgomery J.A. Comparison of the toxicity and metabolism of 9-β-D-arabinosyl-2-fluoroadenine and 9-β-D-arabinofuranosyladenine in human lymphoblastoid cells. Cancer Res. 40:1980;2349-2355.
19. W. Plunkett, V. Gandhi, Cellular metabolism of nucleoside analogs in CLL: implications for drug development, in: B.D. Cheson (Ed.), Chronic Lymphocytic Leukemia: Scientific Advances and Clinical Developments, vol. 1, Marcel Dekker, New York, 1993, pp. 197-219.
20. Robertson L.E., Chubb S., Meyn R.E., Story M., Ford R., Hittelman W.N., Plunkett W. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine. Blood. 81:1993;143-150.
21. Saven A., Carrera C.J., Carson D.A., Beutler E., Piro L.D. 2-chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma. Blood. 80:1992;587-592.
22. Saven A., Piro L.D. The newer purine analogs: significant therapeutic advance in the management of lymphoid malignancies. Cancer Suppl. 72:1993;3470-3483.
23. Seto S., Carrera C.J., Kubota M., Wasson D.B., Carson D.A. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to non-dividing human lymphocytes. J. Clin. Invest. 75:1985;377-383.
24. Seymour J.F., Huang P., Plunkett W., Gandhi V. Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continous infusion schedule. Clin. Cancer Res. 2:1996;653-658.
25. Siaw M.F.E., Coleman M.S. In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. J. Biol. Chem. 259:1984;9426-9433.
26. Simon L.N., Bauer R.J., Tolman R.L., Robins R.K. Calf intestine adenosine deaminase: substrate specificity. Biochemistry. 9:1970;573-577.
27. Spriggs D., Robbins G., Mitchell T., Kufe D. Incorporation of 9-β-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA. Biochem. Pharmacol. 35:1986;247-252.